A detailed history of Edentree Asset Management LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Edentree Asset Management LTD holds 5,800 shares of MRK stock, worth $590,846. This represents 0.23% of its overall portfolio holdings.

Number of Shares
5,800
Previous 5,800 -0.0%
Holding current value
$590,846
Previous $765 Million 6.19%
% of portfolio
0.23%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $1.16 Million - $1.35 Million
-10,200 Reduced 63.75%
5,800 $765 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $50,090 - $54,510
500 Added 3.23%
16,000 $1.74 Billion
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $1.03 Million - $1.14 Million
-10,000 Reduced 39.22%
15,500 $1.6 Billion
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $2.77 Million - $3.02 Million
25,500 New
25,500 $2.94 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Edentree Asset Management LTD Portfolio

Follow Edentree Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edentree Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Edentree Asset Management LTD with notifications on news.